Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.1K
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

2.1K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.1K
Three-Compartment Open Model01:06

Three-Compartment Open Model

1.2K
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
1.2K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

502
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
502
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Model Development for Continuous Carotid Intima-Media Thickness: A Graph-Driven Self-Supervised Learning Approach.

IEEE journal of biomedical and health informatics·2025
Same author

In silico Deployment Modeling of an Everolimus Coated Balloon.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Statistical and Machine Learning Approaches for Virtual Population Generation in In-Silico Cardiovascular Trials.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Computational Framework for Parametric Tissue Modeling.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

A Novel Approach to Distinguish Parkinson's Disease Patients From Healthy Control Subjects Using Speech-Based Task Analysis.

IEEE journal of biomedical and health informatics·2025
Same author

AI Model Passport: Data and system traceability framework for transparent AI in health.

Computational and structural biotechnology journal·2025

Related Experiment Video

Updated: May 3, 2026

Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section
11:00

Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section

Published on: July 19, 2016

11.6K

A Multiscale Parametric Study to Drug Delivery Modeling in Stented Arteries.

Dimitrios S Pleouras, Vasileios S Loukas, Georgia S Karanasiou

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |March 5, 2025
    PubMed
    Summary

    This study models retinoic acid drug delivery in coronary stents. Key factors like blood flow and material properties significantly impact drug accumulation, informing personalized stent design for cardiovascular medicine.

    More Related Videos

    Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
    06:39

    Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

    Published on: February 18, 2020

    6.8K
    In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
    07:00

    In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

    Published on: March 14, 2021

    3.1K

    Related Experiment Videos

    Last Updated: May 3, 2026

    Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section
    11:00

    Experimental Investigation of Secondary Flow Structures Downstream of a Model Type IV Stent Failure in a 180° Curved Artery Test Section

    Published on: July 19, 2016

    11.6K
    Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
    06:39

    Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

    Published on: February 18, 2020

    6.8K
    In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
    07:00

    In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

    Published on: March 14, 2021

    3.1K

    Area of Science:

    • Biomedical Engineering
    • Computational Fluid Dynamics
    • Pharmacology

    Background:

    • Coronary artery disease treatment often involves stenting.
    • Drug-eluting stents (DES) aim to improve outcomes by releasing therapeutic agents.
    • Understanding drug distribution from stents is crucial for optimizing efficacy and minimizing side effects.

    Purpose of the Study:

    • To investigate the dynamic behavior and distribution of retinoic acid within a stented coronary artery.
    • To elucidate the impact of stent design and physiological factors on drug release and accumulation.
    • To provide insights for personalized stent applications in cardiovascular medicine.

    Main Methods:

    • A multiscale computational model for drug delivery was developed and applied to a stented arterial segment.
    • Three-dimensional arterial geometry was reconstructed using optical coherence tomography (OCT) and X-ray angiography.
    • Finite element modeling simulated stent deployment and its influence on drug distribution.

    Main Results:

    • Variations in retinoic acid concentration on the stent, blood flow velocity, polymer porosity, arterial wall porosity, and drug permeability significantly altered drug accumulation.
    • The computational model demonstrated sensitivity to changes in key parameters, highlighting their importance in drug delivery dynamics.
    • Drug distribution patterns were influenced by the interplay between stent characteristics and arterial environment.

    Conclusions:

    • Computational modeling provides valuable insights into retinoic acid behavior in stented arteries.
    • Optimizing stent parameters and considering patient-specific factors can enhance therapeutic outcomes.
    • This research supports the development of advanced, personalized coronary stents for improved cardiovascular treatment.